-
α-Bungarotoxin for Nicotinic Receptor Blockade
2026-08-20
Use α-Bungarotoxin to separate α7 nicotinic acetylcholine receptor signaling from downstream effects in neuronal, trophoblast, and neuroimmune assays. This workflow translates recent placental necroptosis findings into practical controls, dosing pilots, and troubleshooting strategies for reproducible cholinergic research.
-
Recombinant Human Growth Hormone: Assay Logic
2026-08-19
Recombinant Human Growth Hormone can do more than generate a proliferation signal. This guide explains how to connect growth hormone receptor activation with the IGFBP2–THBS1–IGF-1 axis and design more discriminating chondrocyte assays.
-
c-Myc Peptide for Immunoassay Precision
2026-08-19
Use the c-Myc tag peptide as a sequence-defined competitor for antibody-binding control, fusion-protein elution, and assay specificity testing. This workflow-focused guide also shows how the reagent can support careful interpretation of transcription-factor stability studies without confusing tag chemistry with endogenous c-Myc biology.
-
Triiodothyronine and the Beige-Fat Translation Gap
2026-08-18
A translational framework for using Triiodothyronine (T3) to interrogate thyroid hormone signaling alongside the SEMA3E–β-catenin axis in beige adipocyte biology, with practical assay guidance and clear limits on current evidence.
-
Genetically Engineered Mouse Models of Mesothelioma
2026-08-18
Kadariya and colleagues provide a protocol-centered framework for modeling malignant mesothelioma in genetically engineered mice, linking Bap1, Cdkn2a/b, and Nf2 alterations with asbestos exposure, inflammation, and tumor development. The models support mechanistic studies and preclinical testing in immunocompetent settings, while also clarifying how germline and conditional designs can address different research questions.
-
(R)-MG132 as a Proteasome Negative Control
2026-08-17
(R)-MG132 is a stereochemical negative control for separating genuine MG-132 proteasome effects from solvent, scaffold, and cellular stress artifacts. Its strongest use is in paired biochemical and cell-based workflows that test whether protein stability or cancer-metabolism phenotypes are truly proteasome-dependent.
-
FLAG tag Peptide (DYKDDDDK) for Assay Workflows
2026-08-17
Learn how FLAG tag Peptide (DYKDDDDK), SKU A6002, can strengthen upstream recombinant-protein validation when cell viability, proliferation, or cytotoxicity results are inconsistent. This scenario-based guide covers affinity elution, compatibility, handling, interpretation, and practical vendor-selection criteria.
-
Cepharanthine: A Translational Assay Decision Guide
2026-08-16
Cepharanthine is a biscoclaurine alkaloid with linked effects on cell-cycle control, DNA damage, and apoptosis. This guide translates recent organoid and animal evidence into practical assay-selection, formulation, and interpretation strategies without overstating preclinical findings.
-
Phenothiazines, ROS, and Autophagy in Macrophages
2026-08-15
The reference study identifies phenothiazines as host-directed lead compounds that strengthen macrophage antibacterial activity through coordinated reactive oxygen species accumulation, lysosomal activation, and autophagy. Pharmacological inhibition of autophagy or ROS substantially weakened this protection, while perphenazine reduced lesion and inflammatory outcomes in a Salmonella Typhimurium infection model.
-
SOAT1, Lipophagy, and PHMG-Induced Lung Fibrosis
2026-08-14
The reference study identifies sterol O-acyltransferase 1 (SOAT1) as a previously unrecognized driver of PHMG-induced pulmonary fibrosis. By linking SOAT1-dependent cholesteryl ester accumulation in alveolar macrophages to impaired lipophagy and fibroblast activation, the work supports SOAT1 inhibition as a preclinical therapeutic strategy.
-
Filipin III for Membrane Cholesterol Workflows
2026-08-14
Filipin III converts cholesterol distribution into an actionable imaging and membrane-fraction readout for macrophage, vesicle, and pulmonary injury studies. This guide connects cholesterol-rich membrane microdomain analysis with the SOAT1–lipophagy mechanism reported in PHMG-induced fibrosis while emphasizing controls, workflow timing, and interpretation limits.
-
ML365: From TASK1 Assay to Neuroinflammation
2026-08-13
ML365 links selective TASK1 potassium-channel pharmacology with experimental neuroinflammation research. This article presents an assay-triangulation framework that separates channel engagement, inflammasome biology, cognitive phenotype, and compound-specific confounding factors.
-
S-Adenosylmethionine: From Donor to Strategy
2026-08-13
S-Adenosylmethionine is more than a methyl donor: it is a controllable metabolic variable that can reveal enzyme selectivity, guide epigenetic assay design, and strengthen translational decisions. New mechanistic work on the mulberry methyltransferase MaMT4 shows why donor concentration, substrate architecture, and active-site context must be interpreted together.
-
Entinostat (MS-275): HDAC1/3 Research Workflows
2026-08-12
Entinostat (MS-275) combines strong HDAC1/3 activity with a practical workflow for profiling chromatin remodeling, cancer cell responses, and regeneration-linked biology. This guide connects quantitative assay design with troubleshooting strategies that help distinguish target engagement, growth suppression, and cell death.
-
D-Luciferin for Reliable Luciferase Assays
2026-08-12
Learn how D-Luciferin, SKU B6040, can improve the consistency of luciferase-based viability, proliferation, cytotoxicity, ATP, and imaging workflows. This scenario-driven guide covers assay principle, solvent compatibility, storage, optimization, data interpretation, and evidence-based reagent selection.